Supporting Melanoma Research

Melanoma Patients Australia regularly collaborates with academic, clinical and sector partners to advance patient-centred melanoma research. Together, we work to ensure that the latest evidence is translated into compassionate, high-quality supportive care services and programs for people affected by melanoma.

Our Research Priorities

Priority 1

Evidence Based Service Delivery

Priority 2

Informing 
Future Research

Priority 3

Bridging Academia and the Melanoma Community

How we might support your research

Get in touch with us today to discuss your research and explore how we can work together to advance patient centred outcomes.

Collaborator

Co‑investigate, joint grant applications or and formal support for grant bids

Contributor

Consumer perspectives, co‑design, participation in steering committees and as research participants

Connector / Facilitator

Recruitment and promotion via our networks and social channels to reach diverse patient groups

Finding Information About Clinical Trials and Research Opportunities

Access to clinical trials can provide some people with melanoma the opportunity to explore emerging treatments and contribute to advancing melanoma care.

There are several trusted ways to find information about current clinical trials and research. You can also ask your doctor or you can explore the following: 

Melanoma Institute Australia (MIA) 

MIA maintains a comprehensive and regularly updated list of their melanoma clinical trials. Visit their website to explore available trials and eligibility criteria.

Australian Clinical Trials

An Australian Government initiative to provide information and resources to participants, healthcare providers, researchers and industry about taking part in, accessing and running clinical trials.

Melanoma and Skin Cancer Trials (MASC)

MASC is an independent, not‑for‑profit clinical trials group that collaborates with leading researchers to design and deliver clinical trials aimed at improving the prevention, detection and treatment of melanoma and skin cancer.

Australian and international clinical trial registries

The Australian New Zealand Clinical Trials Registry (ANZCTR) and ClinicalTrials.gov, allow you to search for melanoma studies by location, treatment type, or stage of disease. 

Teletrial

Teletrial is a proven model that connects regional, rural, and remote clinical trial sites with a primary site using digital telecommunication. This approach builds local capacity, promotes equitable access to trials, and brings research closer to where patients live.  

Melanoma Patients Australia community channels

MPA community channels including our Facebook pages, regularly share information about research studies and participation opportunities advertised by trusted partners and researchers. Visit our Facebook page and search #research. 

As a supportive care organisation, we can help people understand the clinical trial process by providing clear, reputable, evidence-based information and resources. Call our support line for more information about our services on 1300 884 450.

Current Research

The ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) is a national research program using advanced 3D skin imaging, artificial intelligence and genomic technologies to improve the early detection and diagnosis of melanoma across Australia. Through its network of 15 sites, including many regional and rural locations, ACEMID is generating world-leading evidence to support more accurate, accessible and equitable skin cancer screening. Consumer perspectives have been embedded throughout the program, helping to shape research priorities, communication strategies and future screening models. Melanoma Patients Australia (MPA) is a member of the ACEMID Consumer & Community Engagement Working Group. 

Search